NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

That actually makes good sense to me as well. So if, as you suggested later in this exchange that that is the case, I am not surprised. It is what I kind of expected, that they could not for the main comparison, break them out though they might in ancillary discussion, if possible. They have collected the data, but it may not be readily available for a relevant group of historical patients in the form the FDA expects at this time.

Thanks Senti.